Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Economic costs of nonmedical use of prescription opioids.

Hansen RN, Oster G, Edelsberg J, Woody GE, Sullivan SD.

Clin J Pain. 2011 Mar-Apr;27(3):194-202. doi: 10.1097/AJP.0b013e3181ff04ca.

PMID:
21178601
2.

Economic burden of prescription opioid misuse and abuse.

Strassels SA.

J Manag Care Pharm. 2009 Sep;15(7):556-62. Review.

3.

The burden of the nonmedical use of prescription opioid analgesics.

Gilson AM, Kreis PG.

Pain Med. 2009 Jul;10 Suppl 2:S89-100. doi: 10.1111/j.1526-4637.2009.00668.x. Review.

PMID:
19691688
4.

Economic Burden of Prescription Opioid Misuse and Abuse: A Systematic Review.

Oderda GM, Lake J, RĂ¼dell K, Roland CL, Masters ET.

J Pain Palliat Care Pharmacother. 2015;29(4):388-400. doi: 10.3109/15360288.2015.1101641. Review.

PMID:
26654413
5.

Empirical view of opioid dependence.

Ruetsch C.

J Manag Care Pharm. 2010 Feb;16(1 Suppl B):S9-13. Review.

PMID:
20146549
6.

National drug control policy and prescription drug abuse: facts and fallacies.

Manchikanti L.

Pain Physician. 2007 May;10(3):399-424. Review.

7.

Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.

Meyer R, Patel AM, Rattana SK, Quock TP, Mody SH.

Popul Health Manag. 2014 Dec;17(6):372-87. doi: 10.1089/pop.2013.0098. Review.

8.

The nonmedical use of prescription drugs by adolescents.

Rogers PD, Copley L.

Adolesc Med State Art Rev. 2009 Apr;20(1):1-8, vii. Review.

PMID:
19492687
9.

Costs of occupational circulatory disease.

Leigh JP, Schnall P.

Occup Med. 2000 Jan-Mar;15(1):257-67, v. Review.

PMID:
10702089
10.
11.

Economic burden of endometriosis.

Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL.

Fertil Steril. 2006 Dec;86(6):1561-72. Epub 2006 Oct 23. Review.

PMID:
17056043
12.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
13.

Economic considerations in Alzheimer's disease.

Meek PD, McKeithan K, Schumock GT.

Pharmacotherapy. 1998 Mar-Apr;18(2 Pt 2):68-73; discussion 79-82. Review.

PMID:
9543467
14.

The cost and impact of health conditions on presenteeism to employers: a review of the literature.

Schultz AB, Chen CY, Edington DW.

Pharmacoeconomics. 2009;27(5):365-78. doi: 10.2165/00019053-200927050-00002. Review.

PMID:
19586075
15.

College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C.

Drug Alcohol Depend. 2003 Apr 1;69(3):215-32. Review.

PMID:
12633908
16.

The clinical connection: drugs and crime.

Leukefeld CG.

Int J Addict. 1985 Jun-Jul;20(6-7):1049-64. Review.

PMID:
3908335
17.

The costs of Crohn's disease in the United States and other Western countries: a systematic review.

Yu AP, Cabanilla LA, Wu EQ, Mulani PM, Chao J.

Curr Med Res Opin. 2008 Feb;24(2):319-28. Review.

PMID:
18067689
18.

Current options in the management of opioid dependence: a review.

Bouchard GJ, Faistl KW, Monaco JL.

JAAPA. 2011 May;24(5):41, 47-50. Review. No abstract available.

PMID:
21574531

Supplemental Content

Support Center